NCT01414374

Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency

Prevalence of Genetic Polymorphisms of DMT1 and Ferroportin Enzymes in Adults With Anemia by Iron Deficiency, and Its Influence on the Efficacy of Conventional and Herbal Treatments

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Casa Espirita Terra de Ismael · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

The study aims to investigate the prevalence of genetic polymorphisms in adults with iron deficiency and anemia, and the responses to two different treatments: iron sulphate and a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica). The main outcome will be hemoglobin, measured before and after 6 weeks.

Conditions

• Iron Deficiency Anemia

Interventions

Type	Name	Description
DRUG	Herbal medicine	Patients will receive a combination of Hibiscus sabdariffa (powdered dry plant), 200 mg, BID, and Centella asiatica tincture, 40 drops, BID, for 6 weeks.
DRUG	Iron	Patients will receive iron sulphate, 500 mg, BID, plus orange juice, for 6 weeks.

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-12-01
• Completion: 2013-03-01
• First posted: 2011-08-11
• Last updated: 2015-02-13

Locations

1 site across 1 country: Brazil